, Indirect and mixed-treatment comparison, network, or multipletreatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool, Res Synth Meth, vol.3, issue.2, pp.80-97, 2012.
, Undertaking network meta-analyses. In: Cochrane Handbook for Systematic Reviews of Interventions, vol.2019, pp.285-320
, Meta-analysis of individual participant data: rationale, conduct, and reporting, BMJ, vol.340, 2010.
, Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study, BMC Med, 2020.
, Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015, J Clin Epidemiol
, An overview of methods for network meta-analysis using individual participant data: when do benefits arise?, Stat Methods Med Res, vol.27, issue.5, pp.1351-64, 2018.
, The impact of individual patient data in a network meta-analysis: an investigation into parameter estimation and model selection, Res Synth Methods, vol.9, issue.3, pp.441-69, 2018.
, Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement, JAMA, vol.313, issue.16, pp.1657-65, 2015.
, The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations, Ann Intern Med, vol.162, issue.11, pp.777-84, 2015.
, AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both, BMJ, vol.358, 2017.